Advances in the diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis

Laura E. Moreno Luna, Gregory James Gores

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

In patients with PSC, CCA is the most dreaded complication. The survival of patients with PSC plus CCA is greatly diminished. Neither a specific serum tumor marker nor any imaging studies have been proved to be 100% accurate in the detection of CCA. However, more recently developed techniques such as DIA and FISH have shown to improve on the results in patients with negative routine cytology. On the basis of these data, we now routinely use these studies for the diagnosis of CCA in PSC (Table 1). Patients should be followed yearly with MRI studies. If there is a rapid change in a focal stricture and/or the rapid onset of jaundice, we advise direct cholangiography (usually by endoscopic retrograde pancreatography), and brushings and biopsies of the dominant stricture. Where available, advanced cytologic studies for aneuploidy should be performed.

Original languageEnglish (US)
JournalLiver Transplantation
Volume12
Issue number11 SUPPL. 2
DOIs
StatePublished - Nov 2006

Fingerprint

Sclerosing Cholangitis
Cholangiocarcinoma
Pathologic Constriction
Cholangiography
Aneuploidy
Tumor Biomarkers
Jaundice
Cell Biology
Biomarkers
Biopsy
Survival

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

Advances in the diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis. / Moreno Luna, Laura E.; Gores, Gregory James.

In: Liver Transplantation, Vol. 12, No. 11 SUPPL. 2, 11.2006.

Research output: Contribution to journalArticle

@article{d8c35c1e3e1f408cad38f03f45e396f8,
title = "Advances in the diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis",
abstract = "In patients with PSC, CCA is the most dreaded complication. The survival of patients with PSC plus CCA is greatly diminished. Neither a specific serum tumor marker nor any imaging studies have been proved to be 100{\%} accurate in the detection of CCA. However, more recently developed techniques such as DIA and FISH have shown to improve on the results in patients with negative routine cytology. On the basis of these data, we now routinely use these studies for the diagnosis of CCA in PSC (Table 1). Patients should be followed yearly with MRI studies. If there is a rapid change in a focal stricture and/or the rapid onset of jaundice, we advise direct cholangiography (usually by endoscopic retrograde pancreatography), and brushings and biopsies of the dominant stricture. Where available, advanced cytologic studies for aneuploidy should be performed.",
author = "{Moreno Luna}, {Laura E.} and Gores, {Gregory James}",
year = "2006",
month = "11",
doi = "10.1002/lt.20938",
language = "English (US)",
volume = "12",
journal = "Liver Transplantation",
issn = "1527-6465",
publisher = "John Wiley and Sons Ltd",
number = "11 SUPPL. 2",

}

TY - JOUR

T1 - Advances in the diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis

AU - Moreno Luna, Laura E.

AU - Gores, Gregory James

PY - 2006/11

Y1 - 2006/11

N2 - In patients with PSC, CCA is the most dreaded complication. The survival of patients with PSC plus CCA is greatly diminished. Neither a specific serum tumor marker nor any imaging studies have been proved to be 100% accurate in the detection of CCA. However, more recently developed techniques such as DIA and FISH have shown to improve on the results in patients with negative routine cytology. On the basis of these data, we now routinely use these studies for the diagnosis of CCA in PSC (Table 1). Patients should be followed yearly with MRI studies. If there is a rapid change in a focal stricture and/or the rapid onset of jaundice, we advise direct cholangiography (usually by endoscopic retrograde pancreatography), and brushings and biopsies of the dominant stricture. Where available, advanced cytologic studies for aneuploidy should be performed.

AB - In patients with PSC, CCA is the most dreaded complication. The survival of patients with PSC plus CCA is greatly diminished. Neither a specific serum tumor marker nor any imaging studies have been proved to be 100% accurate in the detection of CCA. However, more recently developed techniques such as DIA and FISH have shown to improve on the results in patients with negative routine cytology. On the basis of these data, we now routinely use these studies for the diagnosis of CCA in PSC (Table 1). Patients should be followed yearly with MRI studies. If there is a rapid change in a focal stricture and/or the rapid onset of jaundice, we advise direct cholangiography (usually by endoscopic retrograde pancreatography), and brushings and biopsies of the dominant stricture. Where available, advanced cytologic studies for aneuploidy should be performed.

UR - http://www.scopus.com/inward/record.url?scp=33751020841&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33751020841&partnerID=8YFLogxK

U2 - 10.1002/lt.20938

DO - 10.1002/lt.20938

M3 - Article

VL - 12

JO - Liver Transplantation

JF - Liver Transplantation

SN - 1527-6465

IS - 11 SUPPL. 2

ER -